Skip to main content

Standards and Regulations Related to BCDMH in Drinking Water

Bromochlorodimethylhydantoin or BCDMH is added to water to disinfect water or control microbial growth on the surfaces of water distribution system components. It possesses antimicrobial properties and is used in many applications, including the treatment of recreational and drinking water.

In groundwater wells, BCDMH is an effective control for slime-forming iron bacteria, thereby improving the aesthetic qualities of the water. BCDMH is typically a mixture of two related chemicals:

  • 1-Bromo-3-chloro-5,5-dimethylhydantoin (CAS# 16079-88-2)
  • 3-Bromo-1-chloro-5,5-dimethylhydantoin (CAS# 126-06-7).

Both chemicals release their chlorine and bromine components in water to create hypochlorous and hypobromous acid, which are the active antimicrobial agents.

BCDMH and FIFRA

Disinfectants such as BCDMH require EPA registration under FIFRA when used, sold or distributed within the United States. FIFRA registration is not a requirement of NSF/ANSI/CAN 60, because NSF/ANSI/CAN 60 is a human health effects standard and BCDMH can be used, sold and distributed in other countries.

Moreover, it is the responsibility of the chemical manufacturer or distributor to follow all applicable laws and regulations, including obtaining FIFRA registration for the U.S. market, and the responsibility of the municipal water utility to follow all applicable federal and state requirements for drinking water treatment and quality.

BCDMH Potential Contaminants

NSF/ANSI/CAN 60 establishes a minimum test battery for all BCDMH products and includes metals of toxicological concern, oxyhalides, and volatile organic compounds (VOCs). Metals analysis includes aluminium, antimony, arsenic, barium, beryllium, cadmium, chromium, copper, lead, manganese, mercury, selenium, and thallium. Oxyhalide analysis includes bromate, chlorate, and perchlorate. VOC analysis targets over sixty volatile organic compounds and includes both regulated and non-regulated compounds. All detected compounds shall not exceed the health effects criteria (SPAC) listed in NSF/ANSI/CAN Standard 600.

Click here to learn more

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • iNADO Partners with NSF to Support Members and Athletes

    May 27, 2026
    iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
    Read the Story
  • NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation

    May 20, 2026
    NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
    Read the Story
  • NSF Annual Review and Impact Report 2025 Now Live

    April 20, 2026
    NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
    Read the Story
  • Visit NSF at Making Pharma 2026

    April 10, 2026
    Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.
    Read the Story